I want to be clear at the outset about what this piece is, and what it is not. Who Gets a Seat at the Table? Lobbying and Access in the UK is not a commentary on global politics, international relations, or any particular social issue. Like most people, I hold strong opinions in my private life, but they are not relevant here. This is instead a reflection on how lobbying and access to government operate within the UK, and on who is permitted to operate in those spaces, and who is not. What follows is about process rather than ideology, access rather than allegiance, and observations drawn from my experience over the past six months working alongside the voluntary, community and social enterprise sector, particularly organisations representing people with complex, long‑term conditions. What has struck me most during this period is not overt resistance or hostility from government, but a quieter and more difficult dynamic to articulate: the sense that some voices are treated as inherently legitimate within policy‑making spaces, while others are cautiously, ever so politely, kept at a distance.
This became especially clear to me during discussions with the Department for Work and Pensions, when I, along with other VCSE leads, was told very plainly that the Department does not work with lobbying organisations. The explanation given was impartiality, engagement with lobby groups was said to risk bias, or at least the perception of bias, and therefore something the Department was obliged to avoid. At the time, this reasoning seemed fair enough. Civil servants are bound by codes of conduct that emphasise objectivity and neutrality, and departments are understandably alert to reputational as well as procedural risk.
The difficulty arose later, once I began to reflect more carefully on how influence actually operates in the UK.
Lobbying, in practice, is happening all the time. It occurs through parliamentary groups, briefings, policy papers and informal networks of expertise and familiarity. It is widely understood that many MPs, peers and ministers are members of organised advocacy or “friends of” groups, which are woven into the fabric of Westminster life. These groups convene discussions, shape narratives, frame both problems and solutions, and often help determine which issues are seen as credible or urgent. None of this is illegal, and much of it is arguably necessary in a system where no decision‑maker can be an expert in everything.
What is harder to reconcile is how this reality sits alongside a firm refusal to engage with certain other forms of organised advocacy. If patient organisations or VCSE groups representing those experiencing harm are characterised as “lobbyists” whose involvement would introduce bias, while other organised interests are engaged with routinely under different labels, then the issue is clearly not lobbying itself. It is the categorisation of who is seen as a legitimate contributor to policy formation, and who is not.
From within the VCSE sector, particularly in patient advocacy, engagement with government rarely feels strategic or polished. It is often reactive, driven by urgency rather than long‑term planning, and rooted in attempts to explain how policy plays out in lived reality. People come forward because systems are not working, because guidance does not align with experience, or because harm is occurring quietly and repeatedly in places that rarely attract sustained attention. These organisations are not generally seeking advantage or preferential treatment; they are trying to prevent damage, often with very limited resources and under considerable emotional strain.
Yet they are frequently treated as though their closeness to affected communities makes them problematic contributors rather than essential ones. Their input is framed as partial rather than evidential, as something to be managed rather than understood. Time and again, engagement is deflected into formal consultations that arrive late in the process, or into correspondence that is acknowledged but has little visible impact.
What troubles me most is how familiar this pattern feels when set against recent UK history. The Post Office Horizon scandal did not occur because nobody raised concerns. The contaminated blood tragedy did not persist because there was no advocacy. Long‑running failures in disability assessments, regulation, housing safety and environmental protection were not invisible; for years, they were articulated by those most affected. In each case, the problem was not the absence of voices, but the absence of sustained access to power at a point when intervention could still have prevented devastating harm.
By the time those voices were finally taken seriously, the damage was already embedded, and the response inevitably took the form of inquiries, apologies and retrospective reform.
This leads to an uncomfortable question that many people in the VCSE sector ask quietly, often among themselves: is access, in practice, shaped by resource? Not in the crude sense of bribery or explicit “pay‑to‑play” arrangements, but in subtler and more consequential ways, the ability to employ policy specialists, to navigate the language and rhythms of Whitehall, to sustain relationships over time, and to remain present even when an issue is no longer politically urgent. Well‑resourced organisations can afford to play that long game; many patient groups simply cannot.
If this observation sounds cynical, it may be because it points to a structural imbalance rather than individual intent. Systems can reproduce inequity without anyone actively choosing it, simply by privileging certain forms of professionalism, familiarity and endurance over others.
This is not an argument against lobbying, nor a criticism of any particular organisation or cause. It is, instead, a question of equity and consistency. If government departments decline to engage with patient or VCSE organisations on the grounds that they represent bias, while simultaneously drawing on the insight and influence of other organised interests, then the system is not neutral. It is selective, and selectivity, however well‑intentioned, has consequences.
So what could change? Not radical overhaul, but a change in approach. There is room to distinguish more clearly between campaigning and evidence, and to recognise that lived experience is not a contaminant but a form of intelligence. There is scope for departments to establish formal, protected routes for VCSE and patient input that are routine rather than exceptional, and that operate upstream of crisis rather than only in response to it. There is also value in being more honest about how influence actually works, and in acknowledging that refusing to engage with some groups does not level the playing field, but instead entrenches the advantage of those already fluent in policy environments.
Above all, there is an opportunity to treat early warning voices not as reputational risks to be managed, but as assets to good governance. Listening earlier is almost always less costly, financially, politically and morally, than dealing later with the aftermath of preventable failure.
What has stayed with me over these months is not anger, but a persistent frustration tinged with sadness. Many of the people trying to be heard are already exhausted, by illness, by bureaucracy, and by systems that seem only partially capable of seeing them. We speak often, as a country, about lessons learned, but lessons only matter if we are prepared to change who we listen to, and when.
The real question is not whether lobbying exists in the UK. It plainly does. The question is whose voices are able to travel far enough, early enough, to make a difference.
Sally